Wet AMD 2 Symposium

Related

• 

  FIDO Study: 10-Year Outcomes of Eyes Receiving Continuous, Fixed-Interval Dosing of Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration

  Ivan J. Suner, MD, MBA

  Annual Meeting Talks

  2019

• 

  Comparison of CRISPR-based Genome Editing of VEGF-A as Treatment Strategy for Choroidal Neovascularization

  Glenn C. Yiu, MD, PhD

  Updates from the Field

  2019

• 

  Episode 158: Journal Club with Dr. Ajay Kuriyan and Dr. Shriji Patel, IVR versus IVA for wet AMD, Protocol T subanalysis, CSR natural history

  Jayanth Sridhar, MD

  Member Podcasts

  2018